LP17846-4
Carbidopa
Active
Description
An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself. Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Part Display Name
- Carbidopa
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- Carbidopa
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP17846-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP17846-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 卡比多巴 Synonyms: α-甲基多巴肼; |
| fr-CA | French (Canada) | Carbidopa |
| et-EE | Estonian (Estonia) | Karbidopa |
| es-ES | Spanish (Spain) | Carbidopa |
| it-IT | Italian (Italy) | Carbidopa |
| tr-TR | Turkish (Turkey) | Karbidopa |
| ru-RU | Russian (Russian Federation) | Карбидопа |
| nl-NL | Dutch (Netherlands) | carbidopa |
| fr-BE | French (Belgium) | Carbidopa |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright